Codons 12 and 13 of H-ras protooncogene interrupt the progression of DNA synthesis catalyzed by DNA polymerase alpha.

Abstract:

:Mutagenesis of protooncogenes has been postulated to contribute to the initiation and progression of human cancer. Activating mutations in the H-ras gene are predominantly single-base substitutions and are most frequently identified at codons 12, 13, and 61. We have analyzed the effects of DNA sequence context at specific codons that are hot spots for ras mutation with respect to abnormalities in copying by purified DNA polymerase alpha, a major eucaryotic replication enzyme. Exon 1 of H-ras gene was inserted into M13 mp19, single-stranded DNA constructs were isolated, and the progression of synthesis by polymerase alpha was measured. Strong termination sites were found in codons 12 and 13. Pausing at these codons is abolished when the template is mutated at the middle base of codon 12, the same alteration that converts H-ras into an activated oncogene. Resistance of codon 12 in double-stranded constructs to digestion with restriction enzymes and computer investigation of the ras sequence suggest that these termination sites are in a region of secondary structure. The frequency of sequence alterations within DNA chains that have been extended past codons 12 and 13 was found to be < 0.01. We consider a variety of mechanisms by which the potential secondary structure involving codons 12 and 13 may contribute to the pausing of DNA polymerase alpha and to the generation of clustered mutations at this site.

journal_name

Cancer Res

journal_title

Cancer research

authors

Hoffmann JS,Fry M,Ji J,Williams KJ,Loeb LA

subject

Has Abstract

pub_date

1993-06-15 00:00:00

pages

2895-900

issue

12

eissn

0008-5472

issn

1538-7445

journal_volume

53

pub_type

杂志文章
  • EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.

    abstract::The RNA-binding protein PNO1 is critical for ribosome biogenesis, but its potential role in cancer remains unknown. In this study, online data mining, cDNA, and tissue microarrays indicated that PNO1 expression was higher in colorectal cancer tissue than in noncancerous tissue, and its overexpression was associated wi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-3238

    authors: Shen A,Chen Y,Liu L,Huang Y,Chen H,Qi F,Lin J,Shen Z,Wu X,Wu M,Li Q,Qiu L,Yu N,Sferra TJ,Peng J

    更新日期:2019-05-01 00:00:00

  • Potentiation by guanine nucleosides of the growth-inhibitory effects of adenosine analogs on L1210 and sarcoma 180 cells in culture.

    abstract::The growth-inhibitory effect of 6-methylmercaptopurine riboside (MMPR) against leukemia L1210 cells in culture was dramatically potentiated by the addition of guanine nucleosides to the medium. In the presence of either deoxyguanosine or guanosine, the concentration of MMPR that caused 50% inhibition of growth was 35 ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Grindey GB,Lowe JK,Divekar AY,Hakala MT

    更新日期:1976-02-01 00:00:00

  • Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine.

    abstract::The effect of 17beta-estradiol on an estrogen receptor-positive human breast cancer cell line (MCF-7) was studied. Low concentrations (10(-9) M) of 17beta-estradiol enhanced the rate of cell proliferation; the overall cell cycle time was shortened; and the proportion of cells in the S phase increased. Higher concentra...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Weichselbaum RR,Hellman S,Piro AJ,Nove JJ,Little JB

    更新日期:1978-08-01 00:00:00

  • Role of gastrin and gastrin receptors on the growth of a transplantable mouse colon carcinoma (MC-26) in BALB/c mice.

    abstract::We recently reported trophic response of transplantable mouse colon cancer cells (MC-26) to pentagastrin, in vivo, and demonstrated gastrin receptors on MC-26 cells, in vitro. In the present study, growth of MC-26 cells in mice, in response to pentagastrin, was studied in relation to binding kinetics and capacity of g...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Singh P,Walker JP,Townsend CM Jr,Thompson JC

    更新日期:1986-04-01 00:00:00

  • In vitro differentiation of teratomas and the distribution of creatine phosphokinase and plasminogen activator in teratocarcinoma-derived cells.

    abstract::Mouse teratocarcinoma cells from embryoid bodies were cultured in vitro to permit their differentiation into a number of cell types. Two enzyme activities, creatine phosphokinase (CPK) and the protease plasminogen activator, were studied to follow the developmental sequence of events in these embryoid body-derived cel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Topp W,Hall JD,Marsden M,Teresky AK,Rifkin D,Levine AJ,Pollack R

    更新日期:1976-11-01 00:00:00

  • The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.

    abstract::Bisphosphonate (BP), a specific inhibitor of osteoclasts, has been widely used as a beneficial agent for the treatment of bone metastases in patients with breast cancer. It is well recognized that BP reduces osteolysis by promoting apoptosis in osteoclasts. However, recent animal and human data suggest that BPs not on...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hiraga T,Williams PJ,Mundy GR,Yoneda T

    更新日期:2001-06-01 00:00:00

  • Unraveling the "known unknowns": lessons and reflections from the new directions in leukemia research 2012 conference.

    abstract::Patients diagnosed with leukemia approach their treatment with the hope of cure despite the effect on their quality of life. Some patients will be cured, others will die from treatment, and some will die of their disease. A common theme at the New Directions in Leukemia Research (NDLR 2012) meeting was that cure will ...

    journal_title:Cancer research

    pub_type:

    doi:10.1158/0008-5472.CAN-12-1832

    authors: White DL,Brown AL,D'Andrea RJ,Rice AM

    更新日期:2012-09-01 00:00:00

  • The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras.

    abstract::Many tumors contain extensive regions of hypoxia. Because hypoxic cells are markedly more resistant to killing by radiation, repeated attempts have been made to improve the oxygenation of tumors to enhance radiotherapy. We have studied the oxygenation of tumor xenografts in nude mice after treatment with the farnesylt...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cohen-Jonathan E,Evans SM,Koch CJ,Muschel RJ,McKenna WG,Wu J,Bernhard EJ

    更新日期:2001-03-01 00:00:00

  • Morphology and anatomic localization of renal microneoplasms and proximal tubule dysplasias induced by four different estrogens in the hamster.

    abstract::Estrogens are known to induce tumors in high frequency in orchiectomized Syrian golden hamsters, but the histogenesis of the tumors is controversial. In order to identify the earliest precursors of the tumors, animals were implanted with pellets of four different estrogens, sacrificed at times ranging up to 6.4 months...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Goldfarb S,Pugh TD

    更新日期:1990-01-01 00:00:00

  • Maintenance of p53 alterations throughout breast cancer progression.

    abstract::Overexpression of the nuclear phosphoprotein p53 is one of the most common abnormalities in primary human cancer and appears to be due to point mutation within a highly conserved region of the p53 gene which then encodes for a mutant, more stable protein. In this study different stages of breast cancer progression wer...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Davidoff AM,Kerns BJ,Iglehart JD,Marks JR

    更新日期:1991-05-15 00:00:00

  • Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide.

    abstract::N-4-Hydroxyphenylretinamide (fenretinide or 4HPR), a derivative of retinoic acid, has been demonstrated to decrease the development of prostate cancer in a rat carcinogenesis model. This study was undertaken to determine if 4HPR is an effective agent for the treatment of established prostate cancer. In vitro, 4HPR was...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pienta KJ,Nguyen NM,Lehr JE

    更新日期:1993-01-15 00:00:00

  • Development of an assay for aryl hydrocarbon (benzo(a)pyrene) hydroxylase in human peripheral blood monocytes.

    abstract::An assay has been developed and measurements of aryl hydrocarbon [benzo(a)pyrene] hydroxylase have been made in peripheral blood monocytes from a human population. Treatment with benz(a)anthracene in cell culture increased aryl hydrocarbon hydroxylase activity from 6.5 to 37-fold in monocytes from each of 25 apparentl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bast RC Jr,Okuda T,Plotkin E,Tarone R,Rapp HJ,Gelboin HV

    更新日期:1976-06-01 00:00:00

  • Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.

    abstract::Glioblastoma is an aggressive brain tumor characterized by an abnormal blood vasculature that is hyperpermeable. Here, we report a novel role for CD93 in regulating angiogenesis in this setting by modulating cell-cell and cell-matrix adhesion of endothelial cells. Tissue microarray analysis demonstrated that vascular ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-3636

    authors: Langenkamp E,Zhang L,Lugano R,Huang H,Elhassan TE,Georganaki M,Bazzar W,Lööf J,Trendelenburg G,Essand M,Pontén F,Smits A,Dimberg A

    更新日期:2015-11-01 00:00:00

  • Androgen sensitivity of the new human breast cancer cell line MFM-223.

    abstract::The mammary carcinoma cell line MFM-223 is characterized by high androgen and low estrogen and progesterone receptor levels. With the dextran charcoal method, androgen binding was determined at 160 fmol/mg protein corresponding to approximately 100,000 binding sites per cell in whole cell binding assays. The estrogen ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hackenberg R,Lüttchens S,Hofmann J,Kunzmann R,Hölzel F,Schulz KD

    更新日期:1991-10-15 00:00:00

  • Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression.

    abstract::In a previous study, we found that the small-molecule epidermal growth factor receptor (EGFR) inhibitor gefitinib (ZD1839, Iressa) blocked cell proliferation at biologically relevant concentrations in approximately one third (6 of 17) of human bladder cancer cell lines examined. Here, we studied the effects of gefitin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1224

    authors: Shrader M,Pino MS,Lashinger L,Bar-Eli M,Adam L,Dinney CP,McConkey DJ

    更新日期:2007-02-15 00:00:00

  • Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.

    abstract::cis-Diammine(1,1-cyclobutanedicarboxylato)platinum (CBDCA) is a nonnephrotoxic but myelosuppressive analogue of cisplatin (DDP) with greatly reduced protein binding and greatly increased renal excretion. Thus, CBDCA might produce undue toxicity in patients with decreased renal function. Twenty-two patients [14 females...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Egorin MJ,Van Echo DA,Tipping SJ,Olman EA,Whitacre MY,Thompson BW,Aisner J

    更新日期:1984-11-01 00:00:00

  • Glycosylation of Recombinant Anticancer Therapeutics in Different Expression Systems with Emerging Technologies.

    abstract::Glycosylation, a posttranslational modification, has a major role in recombinant anticancer therapeutic proteins, as most of the approved recombinant therapeutics are glycoproteins. The constant amino acid sequence of therapeutics determines the enzymatic activity, while the presence of glycans influences their pharma...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-18-0032

    authors: Nadeem T,Khan MA,Ijaz B,Ahmed N,Rahman ZU,Latif MS,Ali Q,Rana MA

    更新日期:2018-06-01 00:00:00

  • Tumor necrosis factor alpha polymorphism correlates with deleterious effects of ultraviolet B light on cutaneous immunity.

    abstract::Intradermally injected tumor necrosis factor alpha (TNF-alpha) mimics the effects of UV B light (UVB) radiation and neutralizing anti-TNF-alpha antibodies abolish the deleterious effects of UVB on induction of contact hypersensitivity suggesting that TNF-alpha is the major mediator of UVB effects on cutaneous immunity...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Vincek V,Kurimoto I,Medema JP,Prieto E,Streilein JW

    更新日期:1993-02-15 00:00:00

  • Identification of the major protein components in breast secretions from women with benign and malignant breast diseases.

    abstract::The protein composition of breast secretions from 99 premenopausal women with benign or malignant breast diseases and from 70 control women without breast pathologies has been studied by using polyacrylamide gel electrophoresis. These fluids have been classified into two types according to their major polypeptide comp...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sánchez LM,Vizoso F,Díez-Itza I,López-Otín C

    更新日期:1992-01-01 00:00:00

  • Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo.

    abstract::Alteration of the phenotype of breast cancers from estrogen-dependent to estrogen-independent growth often leads to the failure of antiestrogenic tumor therapies. We report that overexpression of vascular endothelial growth factor (VEGF) by estrogen-dependent MCF-7 breast cancer cells could abolish estrogen-dependent ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Guo P,Fang Q,Tao HQ,Schafer CA,Fenton BM,Ding I,Hu B,Cheng SY

    更新日期:2003-08-01 00:00:00

  • Sarcoma-negative leukemia-positive transformed cell culture established from a murine sarcoma virus-induced rat bone tumor.

    abstract::Inoculation of the Soehner-Dmochowski isolate of the Moloney strain of murine sarcoma virus (MSV), designated MSV-SD, consistently leads to the development of bone tumors in the susceptible New Zealand black (NB) rats. Two separate cell cultures have been established from 2 individual MSV-SD-induced NB rat bone tumors...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chan JC,East JL,Dmochowski L

    更新日期:1975-09-01 00:00:00

  • CD43, but not P-selectin glycoprotein ligand-1, functions as an E-selectin counter-receptor in human pre-B-cell leukemia NALL-1.

    abstract::B-cell precursor acute lymphoblastic leukemia (BCP-ALL/B-precursor ALL) is characterized by a high rate of tissue infiltration. The mechanism of BCP-ALL cell extravasation is not fully understood. In the present study, we have investigated the major carrier of carbohydrate selectin ligands in the BCP-ALL cell line NAL...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-1459

    authors: Nonomura C,Kikuchi J,Kiyokawa N,Ozaki H,Mitsunaga K,Ando H,Kanamori A,Kannagi R,Fujimoto J,Muroi K,Furukawa Y,Nakamura M

    更新日期:2008-02-01 00:00:00

  • Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.

    abstract::A series of 152 human bladder tumors, 14 bladder tumor cell lines, and 1 immortal urothelial cell line were examined by single-strand conformation polymorphism (SSCP) and designed restriction fragment.length polymorphism analyses for mutations in exons 1 and 2 of the H-ras gene. Nine tumors (6%) contained mutations. T...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Knowles MA,Williamson M

    更新日期:1993-01-01 00:00:00

  • Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3.

    abstract::Telomerase is essential for immortalization of most human cancer cells. Expression of the core telomerase RNA (hTR) and reverse transcriptase (hTERT) subunits is mainly regulated by transcription. However, hTR transcriptional regulation remains poorly understood. We previously showed that the core hTR promoter is acti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1941

    authors: Bilsland AE,Stevenson K,Atkinson S,Kolch W,Keith WN

    更新日期:2006-02-01 00:00:00

  • Surveillance, initial assessment, and subsequent progress of patients with superficial bladder cancer in a prospective longitudinal study. National Bladder Cancer Collaborative Group A (NBCCGA).

    abstract::Through a bladder cancer surveillance protocol, a sizable population of patients suitable for characterizing the dynamics and patterns of recurrent superficial transitional cell carcinoma has been identified. One hundred thirty-three patients have been followed after their first occurrence of transitional cell carcino...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors:

    更新日期:1977-08-01 00:00:00

  • Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells.

    abstract::A body of evidence has shown the existence of a nuclear phosphoinositide cycle in different cell types. The cycle is endowed with kinases as well as phosphatases and phospholipase C (PLC). Among the PLC isozymes, the beta family is characterized by a long COOH-terminal tail that contains a cluster of lysine residues r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Matteucci A,Faenza I,Gilmour RS,Manzoli L,Billi AM,Peruzzi D,Bavelloni A,Rhee SG,Cocco L

    更新日期:1998-11-15 00:00:00

  • Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity.

    abstract::The clinical effects and pharmacokinetics of high-dose uridine were determined in seven patients with advanced-stage cancer and in one healthy volunteer. Uridine was also examined for its effect on 5-fluorouracil toxicity in two patients. Uridine was administered as a 1-hr i.v. infusion at doses of 1 to 12 g/sq m. Pla...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Leyva A,van Groeningen CJ,Kraal I,Gall H,Peters GJ,Lankelma J,Pinedo HM

    更新日期:1984-12-01 00:00:00

  • Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases.

    abstract::In breast cancer bone metastasis, tumor cells stimulate osteoclast-mediated bone resorption, and bone-derived growth factors released from resorbed bone stimulate tumor growth. The alphavbeta3 integrin is an adhesion receptor expressed by breast cancer cells and osteoclasts. It is implicated in tumor cell invasion and...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-4499

    authors: Zhao Y,Bachelier R,Treilleux I,Pujuguet P,Peyruchaud O,Baron R,Clément-Lacroix P,Clézardin P

    更新日期:2007-06-15 00:00:00

  • Radioresistant cancer cells can be conditioned to enter senescence by mTOR inhibition.

    abstract::Autophagy is frequently activated in radioresistant cancer cells where it provides a cell survival strategy. The mTOR inhibitor rapamycin activates autophagy but paradoxically it also enhances radiosensitivity. In this study, we investigated the mechanisms of these opposing actions in radiation-resistant glioma or par...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-3516

    authors: Nam HY,Han MW,Chang HW,Lee YS,Lee M,Lee HJ,Lee BW,Lee HJ,Lee KE,Jung MK,Jeon H,Choi SH,Park NH,Kim SY,Kim SW

    更新日期:2013-07-15 00:00:00

  • SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line.

    abstract::The therapeutic potential of cisplatin, one of the most active and widely used anticancer drugs, is severely limited by the occurrence of cellular resistance. In this study, using budding yeast Saccharomyces cerevisiae as a model organism to identify novel drug resistance genes, we found that disruption of the yeast g...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Schenk PW,Boersma AW,Brandsma JA,den Dulk H,Burger H,Stoter G,Brouwer J,Nooter K

    更新日期:2001-10-01 00:00:00